Expression of cell-surface antigens in acute promyelocytic leukaemia (Q35205497)

7 August 2017

1 reference

title

Expression of cell-surface antigens in acute promyelocytic leukaemia (English)

1 reference

7 August 2017

1 reference

Elisabeth Paietta

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Best Practice and Research: Clinical Haematology

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

369-385

1 reference

Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Immunophenotypic and enzymatic studies do not support the concept of mixed monocytic-granulocytic differentiation in acute promyelocytic leukaemia (M3): a study of 44 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid mallignancies but is also a characteristic of a subset of acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Antigen expression patterns reflecting genotype of acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Adhesion receptors on haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

All-trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Adhesion molecules in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Variant and masked translocations in acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Submicroscopic insertion of RARalpha gene into chromosome 15 in two cases of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Acute promyelocytic leukemia toluidine blue subtype

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Human CD38: a (r)evolutionary story of enzymes and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Multidrug resistance in haematological malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Low incidence of MDR1 expression in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Classical multidrug resistance in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Retinoic acid resistance in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900042-2

7 January 2021

10.1016/S1521-6926(03)00042-2

Identifiers

DOI

1 reference

7 August 2017

1 reference